Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1053)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
200
Price
$483.85
Total Value
$96.77K
Shares Held After
47,223
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
160
Price
$482.66
Total Value
$77.23K
Shares Held After
47,423
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,048
Price
$481.92
Total Value
$505.05K
Shares Held After
47,583
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,360
Price
$480.86
Total Value
$1.13M
Shares Held After
48,631
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
936
Price
$479.66
Total Value
$448.96K
Shares Held After
50,991
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,545
Price
$478.93
Total Value
$739.95K
Shares Held After
51,927
% of Holdings
2.9%
Denali Therapeutics Inc. (DNLI)
Thornberry Nancy — Director
Shares
615
Price
$23.74
Total Value
$14.60K
Shares Held After
19,686
% of Holdings
3.0%
Denali Therapeutics Inc. (DNLI)
Thornberry Nancy — Director
Shares
10,824
Price
$22.85
Total Value
$247.33K
Shares Held After
20,301
% of Holdings
34.8%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
656
Price
$2.75
Total Value
$1.80K
Shares Held After
114,805
% of Holdings
0.6%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
391
Price
$27.12
Total Value
$10.60K
Shares Held After
35,559
% of Holdings
1.1%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
2,800
Price
$26.38
Total Value
$73.85K
Shares Held After
35,950
% of Holdings
7.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
KIRITSY CHRISTOPHER P — Director
Shares
313
Price
$157.00
Total Value
$49.14K
Shares Held After
250
% of Holdings
55.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,375
Price
$27.12
Total Value
$37.29K
Shares Held After
38,773
% of Holdings
3.4%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
9,852
Price
$26.38
Total Value
$259.86K
Shares Held After
40,148
% of Holdings
19.7%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
18,500
Price
$35.12
Total Value
$649.64K
Shares Held After
235,244
% of Holdings
7.3%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
625
Price
$27.12
Total Value
$16.95K
Shares Held After
14,894
% of Holdings
4.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
4,481
Price
$26.38
Total Value
$118.19K
Shares Held After
15,519
% of Holdings
22.4%
Maze Therapeutics, Inc. (MAZE)
Courtney Phillips — GC and Corp. Secretary
Shares
243
Price
$27.12
Total Value
$6.59K
Shares Held After
9,019
% of Holdings
2.6%
Maze Therapeutics, Inc. (MAZE)
Courtney Phillips — GC and Corp. Secretary
Shares
1,738
Price
$26.38
Total Value
$45.84K
Shares Held After
9,262
% of Holdings
15.8%
Autolus Therapeutics plc (AUTL)
Piccina Cintia — U.S. CCO&Country Gen Manager
Shares
6,713
Price
$2.34
Total Value
$15.68K
Shares Held After
13,287
% of Holdings
33.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
1,590
Price
$80.00
Total Value
$127.20K
Shares Held After
4,770
% of Holdings
25.0%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
5,387
Price
$80.00
Total Value
$430.96K
Shares Held After
13,320
% of Holdings
28.8%
Ascendis Pharma A/S (ASND)
HOLTUG LARS — Director
Shares
236
Price
$264.13
Total Value
$62.33K
Shares Held After
4,000
% of Holdings
5.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
McCourt Marion — EVP Commercial
Shares
1,215
Price
$850.00
Total Value
$1.03M
Shares Held After
13,134
% of Holdings
8.5%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
2
Price
$80.98
Total Value
$161.96
Shares Held After
13,499
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
9
Price
$80.98
Total Value
$728.82
Shares Held After
315,328
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
10
Price
$80.98
Total Value
$809.80
Shares Held After
322,588
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
511
Price
$80.17
Total Value
$40.97K
Shares Held After
13,501
% of Holdings
3.6%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
22,090
Price
$80.17
Total Value
$1.77M
Shares Held After
315,337
% of Holdings
6.5%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
26,542
Price
$80.17
Total Value
$2.13M
Shares Held After
322,598
% of Holdings
7.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
Guarini Kathryn — Director
Shares
400
Price
$850.00
Total Value
$340.00K
Shares Held After
603
% of Holdings
39.9%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
400
Price
$90.00
Total Value
$36.00K
Shares Held After
2,845
% of Holdings
12.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
18,232
Price
$89.35
Total Value
$1.63M
Shares Held After
79,762
% of Holdings
18.6%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
1,225
Price
$115.44
Total Value
$141.41K
Shares Held After
4,242
% of Holdings
22.4%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
5,621
Price
$114.58
Total Value
$644.04K
Shares Held After
5,467
% of Holdings
50.7%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
1,606
Price
$113.72
Total Value
$182.63K
Shares Held After
11,088
% of Holdings
12.7%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
974
Price
$112.40
Total Value
$109.47K
Shares Held After
12,694
% of Holdings
7.1%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
1,537
Price
$111.37
Total Value
$171.18K
Shares Held After
13,668
% of Holdings
10.1%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
23,770
Price
$110.70
Total Value
$2.63M
Shares Held After
15,205
% of Holdings
61.0%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
23,600
Price
$109.35
Total Value
$2.58M
Shares Held After
38,975
% of Holdings
37.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
25,131
Price
$7.19
Total Value
$180.69K
Shares Held After
4,177,215
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
25,131
Price
$7.19
Total Value
$180.69K
Shares Held After
4,177,215
% of Holdings
0.6%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
658
Price
$100.00
Total Value
$65.80K
Shares Held After
616
% of Holdings
51.6%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Davis George Eric — EVP, Chief Legal Officer
Shares
17,557
Price
$66.28
Total Value
$1.16M
Shares Held After
61,003
% of Holdings
22.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
27,000
Price
$9.47
Total Value
$255.74K
Shares Held After
827,000
% of Holdings
3.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
10,000
Price
$80.06
Total Value
$800.60K
Shares Held After
837,991
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$510.05
Total Value
$81.61K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$508.36
Total Value
$40.67K
Shares Held After
324,603
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$506.27
Total Value
$20.25K
Shares Held After
324,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$505.20
Total Value
$20.21K
Shares Held After
324,723
% of Holdings
0.0%
Showing 651–700 of 1053 transactions (page 14 of 22)